Evaluation of thyroid hormones in children receiving carbamazepine or valproate: A prospective study

Ihsan Kafadar, Betül Aydin Kiliç, Mujde Arapoglu, Koray Yalçin, Nazan Dalgiç

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

The aim of this study was to determine the alterations in thyroid function during carbamazepine or valproate monotherapy in a prospective study. Forty patients treated with valproate, 33 patients treated with carbamazepine, and 36 control patients, all aged between 2 and 18 years, were enrolled in our study. Serum levels of thyroid hormones were measured before the beginning of the antiepileptic therapy and at 6 and 12 months of treatment. Carbamazepine-treated patients showed mean serum thyroid hormone levels significantly lower than baseline evaluation and the control group. Thyroid-stimulating hormone levels at 6 and 12 months were not significantly different in carbamazepine treated patients. Serum hormone levels did not change during valproate treatment. Thyroid-stimulating hormone levels were significantly higher at the 12th month of valproate treatment. Our data suggest that although carbamazepine causes significant alterations in thyroid hormone levels, these changes do not lead to clinical symptoms at the follow-up period of 12 months.

Original languageEnglish
Pages (from-to)63-68
Number of pages6
JournalJournal of Child Neurology
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 2014
Externally publishedYes

Keywords

  • Carbamazepine
  • Children
  • Epilepsy
  • Thyroid functions
  • Valproate

Fingerprint

Dive into the research topics of 'Evaluation of thyroid hormones in children receiving carbamazepine or valproate: A prospective study'. Together they form a unique fingerprint.

Cite this